Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Nature Communications
|
April 12, 2022
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma
Jeppe Sejerø Holm, Samuel A Funt, Annie Borch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, et al.
Science Translational Medicine
|
August 26, 2021
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
Ronglai Shen, Michael A Postow, Matthew Adamow, et al.
Journal for Immunotherapy of Cancer
|
August 16, 2023
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
Siri Amanda Tvingsholm, Marcus Svensson Frej, Vibeke Mindahl Rafa, et al.
Frontiers in Immunology
|
April 18, 2024
IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition
Annie Borch, Ibel Carri, Birkir Reynisson, et al.
The Journal of Clinical Investigation
|
September 8, 2020
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor
Justin Taylor, Mark Ta Donoghue, Caleb Ho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2026
Neoadjuvant nivolumab with or without ipilimumab for cisplatin-ineligible patients with muscle-invasive bladder cancer
Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran, et al.
Clinical Genitourinary Cancer
|
June 8, 2022
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy
Min Yuen Teo, Brendan J Guercio, Arshi Arora, et al.
JCO Precision Oncology
|
June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype
Nima Almassi, Karissa Whiting, Antoun Toubaji, et al.
Nature Immunology
|
July 28, 2022
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine
Ramin Sedaghat Herati, David A Knorr, Laura A Vella, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Nature Communications
|
April 12, 2022
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma
Jeppe Sejerø Holm, Samuel A Funt, Annie Borch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, et al.
Science Translational Medicine
|
August 26, 2021
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
Ronglai Shen, Michael A Postow, Matthew Adamow, et al.
Journal for Immunotherapy of Cancer
|
August 16, 2023
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
Siri Amanda Tvingsholm, Marcus Svensson Frej, Vibeke Mindahl Rafa, et al.
Frontiers in Immunology
|
April 18, 2024
IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition
Annie Borch, Ibel Carri, Birkir Reynisson, et al.
The Journal of Clinical Investigation
|
September 8, 2020
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor
Justin Taylor, Mark Ta Donoghue, Caleb Ho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2026
Neoadjuvant nivolumab with or without ipilimumab for cisplatin-ineligible patients with muscle-invasive bladder cancer
Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran, et al.
Clinical Genitourinary Cancer
|
June 8, 2022
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy
Min Yuen Teo, Brendan J Guercio, Arshi Arora, et al.
JCO Precision Oncology
|
June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype
Nima Almassi, Karissa Whiting, Antoun Toubaji, et al.
Nature Immunology
|
July 28, 2022
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine
Ramin Sedaghat Herati, David A Knorr, Laura A Vella, et al.
Page
of 8